Opioids in chronic pain management: Navigating the clinical and regulatory challenges

Journal of Family Practice

Volumn 53, Issue SUPPL. 6, 2004, Pages

  Gallagher, Rollin ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE;

ADDICTION; CHRONIC PAIN; COMORBIDITY; DRUG DEPENDENCE; DRUG MISUSE; DRUG TOLERANCE; HUMAN; LEGAL ASPECT; MEDICAL DOCUMENTATION; MEDICAL RECORD; PATIENT CARE; PATIENT MONITORING; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; RISK; SIDE EFFECT; SUBSTANCE ABUSE;

ANALGESICS, OPIOID; CHRONIC DISEASE; DECISION MAKING; DRUG TOLERANCE; HUMANS; PAIN; PHYSICIAN'S PRACTICE PATTERNS; SUBSTANCE-RELATED DISORDERS;

EID: 5144220484     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Anon. Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis, and Juvenile Chronic Arthritis. Glenview, ILL: American Pain Society; 2002.
2. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60:1524-1534.
3. Department of Veterans Affairs. Veterans Health Administration web site. Pain-The 5th vital sign. Available at: http://www1.va.gov/anesthesia/page.cfm? pg=6. Accessed May 19, 2004.
4. Miaskowski C, Cleary J, Burney R, et al. Guideline for the management of cancer pain in adults and children. Glenview, IL: American Pain Society; 2004.
5. Jovey RD, Ennis J, Gardner-Nix J, et al. Use of opioid analgesics for the treatment of chronic noncancer pain - a consensus statement and guidelines from the Canadian Pain Society, 2002. Pain Res Manag. 2003;8(suppl A):3A-28A.
6. Anon. The management of persistent pain in older persons. J Am Geriatr Soc. 2002;50 (suppl 6):S205-S224.
7. Argoff C, Bruckenthal P, Carmichael B, Epstein K, McCarberg B, Ray J. Neuropathic pain. Austin, Texas: Texas Academy of Family Physicians, Primary Care Education Group: 2004.
8. Joint Commission on Accreditation of Healthcare Organizations. Joint Commission Resources web site. Pain Assessment and Management Standards-Ambulatory Care, Available at: http://www.jcrinc.com/subscribers/ perspectives.asp?durki=3240. Accessed May 19, 2004.
9. Federation of State Medical Boards of the United States, Inc. Federation of State Medical Boards web site. Model Policy for the Use of Controlled Substances for the Treatment of Pain. Available at: http://www.fsmb.org/. Accessed May 18, 2004.
10. Fishman SM, Papazian JS, Gonzalez S, Riches PS, Gilson A. Regulating opioid prescribing through prescription monitoring programs: Balancing drug diversion and treatment of pain. Pain Med. In press.
11. Heit HA, Covington E, Good P. Dear DEA. Pain Med. In press.
12. American Academy of Pain Mediane, American Pain Society, American Society of Addiction Medicine. Public policy statement on the rights and responsibilities of healthcare professionals in the use of opioids for the treatment of pain. Pain Med. In press.
13. Anon. A joint statement from 21 health organizations and the Drug Enforcement Administration. Promoting pain relief and preventing abuse of pain medications: a critical balancing act. J Pain Symptom Manage. 2002;24:147.
14. Potter M, Schafer S, Gonzalez-Mendez E, et al. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract. 2001;50:145-151.
15. Portenoy RK. Chronic opioid therapy for persistent non-cancer pain: can we get past the bias? Am Pain Soc Bull. 1991;1:1,4-5.
16. Harden RN. Chronic opioid therapy: another reappraisal Am Pain Soc Bull. 2002;12:1,8-12.
17. Savage SR. Opioid use in the management of chronic pain. Med Clin North Am. 1999;83:761-786.
18. Gardner-Nix J. Principles of opioid use in chronic noncancer pain. CMAJ. 2003;169:38-43.
19. Gallagher RM. Primary care and pain medicine. A community solution to the public health problem of chronic pain. Med Clin North Am. 1999;83: 555-583.
20. Hill JL, Zacny JP. Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers. Psychophamacology (Berl). 2000;152:31-39.
21. Walker DJ, Zacny JP. Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers. J Pharmacol Exp Ther. 1999;289:1454-1464.
22. Walker DJ, Zacny JP, Galva KE, Lichtor JL Subjective, psychomotor, and physiological effects of cumulative doses of mixed-action opioids in healthy volunteers. Psychopharmacology (Berl). 2001;155:362-371.
23. Walker DJ, Zacny JP. Subjective, psychomotor, and analgesic effects of oral codeine and morphine in healthy volunteers. Psychopharmacology (Berl). 1998;140:191-201.
24. Zacny JP, Goldman RE. Characterizing the subjective, psychomotor, and physiological effects of oral propoxyphene in non-drug-abusing volunteers. Drug Alcohol Depend. 2004;73:133-140.
25. Zacny JP, Gutierrez S. Characterizing the subjective, psychomotor, and physiological effects of oral oxycodons in non-drug-abusing volunteers. Psychopharmacology (Berl). 2003;170:242-254.
26. Zacny JP. Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers. Psychopharmacology (Berl). 2003;165:146-156.
27. Menefee LA, Frank ED, Crerand C, et al. The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. Pain Med. 2004;5:42-49.
28. Gallagher RM. Pain and performance: are opioids the answer? Pain Med. 2002;3:1-2.
29. Kouyanou K, Pither CE, Wessely S. Medication misuse, abuse and dependence in chronic pain patients. J Psychosom Res. 1997;43:497-504.
30. Chabal C, Erjavec MK, Jacobson L, Mariano A, Chaney E. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain. 1997;13:150-155.
31. Reid MC, Engles-Horton U, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17:173-179.
32. Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992;8:77-85.
33. Perry S, Heidrich G. Management of pain during debridement: a survey of U.S. bum units. Pain. 1982;13:267-230.
34. Miyoshi HR, Leckband SG. Systemic opioid analgesics. In: Loeser JD, Butler SH, Chapman CR, Turk DC, eds. Borneo's Management of Pain. 3rd ed. New York, NY: Lippincott Williams & Wilkins; 2000:1695.
35. Brown RL, Patterson JJ, Rounds LA, Papasouliotis O. Substance abuse among patients with chronic back pain. J Fam Pract. 1996;43:152-160.
36. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration, Office of Applied Studies web site. Emergency department trends from the Drug Abuse Warning Network, Final estimates 1995-2002. Available at: http://dawninfo.samhsa.gov/pubs_94_02/edpubs/ .2002final/file/EDTrendFinal02AllText.pdf. Accessed June 30, 2004.
37. Marcus DA. Tips for managing chronic pain. Implementing the latest guidelines. Postgrad Med. 2003;113:49-56, 59.
38. Gallagher RM, Verma S. Biopsychosocial pain medicine: Integrating medical, psychiatric, and behavioral therapies. Semin Neurosurg. 2004;15:31-46.
39. American Academy of Pain Medicine, American Pain Society, American Society of Addiction Medicine. Definitions related to the use of opioids for the treatment of pain. A consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. Available at: http://www.ampainsoc.org/ advocacy/opioids2.htm. Accessed May 18, 2004.
40. Fudin J, Levasseur DJ, Passik SD, Kirsh KL, Coleman J. Chronic pain management with opioids in patients with past or current substance abuse problems. J Pharm Pract. 2003;16:291-308.
41. American Academy of Pain Management web site. Prescribing opioids, relieving patient suffering and staying out of personal trouble with regulators. Reprising old ideas and offering new suggestions. Available at: http://www.aapainmanage.org/litetature/PainPrac/V12N3.Cole.PrescribingOpioids. pdf. Accessed May 19, 2004.
42. Prater CD, Zylstra RG, Miller KE. Successful pain management for the recovering addicted patient. Prim Care Companion J Clin Psychiatry. 2002;4:125-131.
43. Dunbar SA, Katz NP. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases. J Pain Symptom Manage. 1996;11:163-171.
44. Wesson DR, Ling W, Smith DE. Prescription of opioids for treatment of pain in patients with addictive disease. J Pain Symptom Manage. 1993;8:289-296.
45. Fishbain DA. Report on the prevalence of drug/alcohol abuse and dependence in chronic pain patients (CPPs). Subst Use Misuse. 1996;31:945-946.
46. Warner LA, Kessler RC, Hughes M, Anthony JC, Nelson CB. Prevalence and cor relates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:219-229.
47. Coombs RB, Jarry JL, Santhiapillai Ac, Abrahamsohn RV, Atance CM. The SBAP: a new screening instrument for identifying potential opioid abuse in the man agement of chronic nonmalignant pain in general medical practice. Pain Res Manag. 1996;1:155-162.
48. Butler S, Budman S, Fernanda K, Benoit C, Jamison R. Validation of screener and opioid assessment for patients with pain [abstract]. J Pain. 2004;5;(3 suppl 1):S111.
49. Buchsbaum DG, Buchanan RG, Center RM, Schroll SH, Lawton MJ. Screening for alcohol abuse using CAGE scores and likelihood ratios. Ann Intern Med. 1991;115:774-777.
50. US Department of Transportation, national Highway Traffic Safety Administration web site. Alcohol screening and brief intervention in the medical setting. Available at: http://www.nhtsa.dot.gov/people/injury/ alcohol/alcohol_screening/Alcohol_index.html. Accessed May 21, 2004.
51. Fishman SM, Bandman TB, Edwards A, Borsook D. The opioid contract in the management of chronic pain. J Pain Symptom Manage. 1999;18:27-37.
52. Fishman SM, Mahajan G, Jung SW, Wilsey BL. The trilateral opioid contract Bridging the pain clinic and the primary care physician through the opioid contract. J Pain Symptom Manage. 2002;24:335-344.
53. Paul BD, Shimomura ET, Smith ML. A practical approach to determine cutoff concentrations for opiate testing with simultaneous detection of codeine, morphine, and 6-acetylmorphine in urine. Clin Chem. 1999;45:510-519.
54. Zacher JL, Givone DM. False-positive urine opiate screening associated with fluoroquinolone use. Ann Pharmacother. 2004;38:1525-1528.
55. Fudin J, Levasseur DJ, Passik SD, Kirsh KL, Coleman J. Chronic pain management with opioids in patients with past or current substance abuse problems. J Pharm Proct. 2003;16:291-308.
56. US Department of Justice. Drug Enforcement Administration web site. Dont be scammed by a drug abuser. Available at http://www.deadiversion.usdoj.gov/ pubs/brothures/drugabuser.htm. Accessed May 21, 2004.